The Synergy Trap: Set the Walk-Away Price Before the Bidding Starts
In a competitive sale, the winning bid can hand the seller all the value the deal was supposed to create. Boards should fix their maximum price before bidding begins.
Every board that has approved an acquisition has heard the case for stretching on price; the target is scarce, a rival is bidding, and the synergies will cover the premium. That case can turn a sound strategic acquisition into a poor investment, because competition can increase the portion of value transferred to the seller without increasing the benefits available to the winning buyer.
WHOSE SYNERGY IS IT?
Synergy is the incremental benefit of combining two businesses, net of implementation costs and adverse effects. It exists only in the buyer’s hands, and it is not guaranteed. Capturing cost savings usually means paying severance, closing facilities, and converting systems. These disruptions can drive away the customers and employees the deal was meant to keep. Paying away all anticipated synergy leaves the buyer bearing implementation risk without retaining incremental economic gain.
To illustrate, assume a target is worth $500 million on its own, and the buyer expects to add $100 million of net synergies. At $600 million, the seller collects the entire benefit, and after transaction expenses the buyer is worse off than if it had just walked away. At $550 million, the buyer keeps half the expected gain and has a margin for error. A rival with different synergies may rationally bid more, and that is a reason to lose the auction, not to match the bid.
SET THE NUMBER FIRST
The board should fix its maximum price, and the conditions attached to it, before competitive pressure and money already spent cloud its judgment. The ceiling starts with what the target is worth on its own, plus the synergies the buyer can realistically capture, minus deal costs. At that price, the deal must still earn the return the company requires on its capital. And each synergy counts once; if it is already in the cash-flow forecast, it cannot also justify a premium.
COMPETE ON CERTAINTY, NOT PRICE
Price is not the only way to win. A buyer offering a lower headline price may nevertheless present a more valuable proposal where financing and regulatory feasibility materially improves the expected realization. A board at its ceiling should ask what else it can offer the seller before it asks for more authority.
HOLDING THE LINE
Executives become attached to deals through enthusiasm, reputation, competitive pressure, and time already invested. Three arguments for exceeding the number deserve skepticism:
- “We can finance it.” Access to substantial funding does not justify overpayment, and maximum leverage can leave too little capacity to absorb normal fluctuations.
- “It is accretive.” Earnings per share accretion does not replace discounted cash-flow analysis or risk-adjusted return evaluation.
- “We have come this far.” Expenditure incurred investigating a target does not increase its economic worth.
Walking away from a contested auction is rarely comfortable. However, a board that fixes its number in advance, and requires fresh approval whenever the deal changes, keeps the value of the acquisition on its own side of the table. Boards should consult experienced M&A counsel and financial advisors before authorizing a bid.
Klugy Mathurin, Senior Associate. Contact via email at kmathurin@gkglaw.com.
Note: This article should not be construed as legal advice or legal opinion on any specific facts or circumstances. The reader is urged to consult legal counsel or other advisors concerning his/her own situation and specific legal questions.
